Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» BBT-877
BBT-877
Bridge doses first patient in Phase lla trial of IPF therapy
Clinical Trials Arena
Thu, 04/13/23 - 11:55 am
Bridge Biotherapeutics
clinical trials
BBT-877
IPF
Citing toxicity concerns, Boehringer Ingelheim drops short-lived IPF pact — keeping $1B+ in its pocket
Endpoints
Wed, 11/11/20 - 11:07 am
Boehringer Ingelheim
IPF
Bridge Biotherapeutics
BBT-877
Looking for Ofev follow-up, Boehringer picks up Bridge Biotherapeutics' IPF med for $50M
Fierce Biotech
Thu, 07/18/19 - 11:38 am
Boehringer Ingelheim
Bridge Biotherapeutics
Ofeva
IPF
BBT-877